comparemela.com

Carl Kraus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aquestive Therapeutics, Inc (NASDAQ:AQST) Q3 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Aquestive Therapeutics Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.

Ernie tothSteve wargackiJason butlerDan barberCarl krausBennett watsonKen marshallAquestive therapeutics incExchange commission onMost valuable financial companiesAquestive therapeuticsCall transcript novemberAquestive therapeutics third quarterChief executive officerChief financial officerChief medical officer

Aceragen (ACGN) Announces Recommendation of Data Monitoring Committee in Terra Study

Aceragen (ACGN) Announces Recommendation of Data Monitoring Committee in Terra Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Carl krausDepartment of defense threat reduction agencyData monitoring committeeAceragen incChief medicalDefense threat reduction agencyFast track designationOrphan drug designationQualified infectious disease product

Idera Bolsters Rare Disease Portfolio with Aceragen Buyout

Two rare disease companies - Idera Pharmaceuticals and Aceragen - are merging to pursue the common goal of an FDA approval that could come as early as 2024.

United statesJohn taylorCarl krausJohn kirbyDaniel salainUs defense threat reduction agencyIdera pharmaceuticalsFast trackQualified infectious disease productThreat reduction agencyChief medical officer carl krausChief operating officer danielGeneral counsel bryant limChief financial officer john kirbyNovaquest the durhamDera bolsters rare disease portfolio with aceragen buyout

Idera Pharma (IDRA) Acquires Aceragen

Idera Pharma (IDRA) Acquires Aceragen
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomJames geraghtyRon wootenCarl krausDaniel salainMaxine gowenMichael doughertyJohn taylorWedbush pacgrowCandy jordanCristina csimmaJohn kirbyFarber diseaseIdera pharmaceuticals incFenwick west

Biopharma deal: NovaQuest-backed Aceragen buys Arrevus

RESEARCH TRIANGLE PARK - The biopharmaceutical company Aceragen, which is backed by NovaQuest Capital Management, announced that it has acquired Arrevus, Inc.,

John taylorCarl krausArrevus incNovaquest capital managementCystic fibrosisChief medical

vimarsana © 2020. All Rights Reserved.